Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Atherosclerosis|July 6, 2010
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke preventionMaurizio Paciaroni, Giancarlo Agnelli, Walter Ageno, et al.
European Urology Open Science|November 10, 2022
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer RegistryAnders Bjartell, Luis Costa, Gero Kramer, et al.
Tumori|May 2, 2018
<sup>223</sup>Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experienceGiuseppe Boni, Sara Mazzarri, Claudia Cianci, et al.
Oncotarget|July 14, 2016
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinibCristian Lolli, Umberto Basso, Lisa Derosa, et al.
Investigational New Drugs|August 26, 2016
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patientsTeresa Di Desidero, Lisa Derosa, Luca Galli, et al.
Journal of Translational Medicine|February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access programGiovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.
Frontiers in Oncology|September 2, 2022
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitorsGiandomenico Roviello, Martina Catalano, Ugo De Giorgi, et al.
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
Urologic Oncology|February 7, 2018
Association among metabolic syndrome, inflammation, and survival in prostate cancerVincenza Conteduca, Orazio Caffo, Luca Galli, et al.
Radiation Oncology (London, England)|January 23, 2016
[(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary resultsFrancesco Pasqualetti, Marco Panichi, Aldo Sainato, et al.
Pageof 15